EMA Panel Backs Xofluza for Influenza, Put up-Exposure Prophylaxis
At its November meeting, the Committee for Medicinal Merchandise for Human Expend (CHMP) rapid approval of the antiviral baloxavir marboxil (Xofluza, Roche) for therapy and put up-publicity prophylaxis of uncomplicated influenza in of us used 12 years and older. The…